7498 Results (Page 228 of 300)
Pharmaceuticals Markets Research Reports
Thailand Anti Aging Therapeutics Market Analysis
Thailand's anti-ageing therapeutics market is expected to witness growth from $1 Mn in 2022 to $3 Mn in 2030 with a CAGR of 16,87% for the year 2022-2030. As Thailand is one of the most popular destinations for medical tourism in anti-ageing treatments, the market in Thailand has enormous potential and is projected to grow during the forecast period. The Thailand anti-ageing therapeutics market is segmented by product, treatment, target group, type of ageing, type of molecules, mechanism of action, ingredient, and by distribution channel. Tulip Group, Algaeba, and Bo International are some of the leading companies in the market.
Philippines Sleep Disorders Market Analysis
This report presents a strategic analysis of the Philippines Sleep Disorders Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Philippines Sleep Disorders Market, offering unmatched value, accuracy and expert insights.
New Zealand Retail Pharmacy Market Analysis
This report presents a strategic analysis of the New Zealand Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the New Zealand Retail Pharmacy Market, offering unmatched value, accuracy and expert insights.
Indonesia Oncology Drugs Market Analysis
By 2030, it is anticipated that the Indonesia oncology drugs market will reach a value of $xx Bn from $1.18 Bn in 2022, growing at a CAGR of xx% during 2022-2030. The oncology drug market in Indonesia is dominated by a few large pharmaceutical companies such as Bio Farma, Innogene by Kalbe Farma and Takeda Pharma. The oncology market in Indonesia is segmented into different therapeutic areas and different treatment types. The major factors affecting the Indonesian oncology drugs market are the increasing disease burden of non-communicable diseases like cancer and the lack of healthcare facilities for cancer treatment in most areas of Indonesia.
India Neurology Drugs Market Analysis
This report presents a strategic analysis of the India Neurology Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the India Neurology Drugs Market, offering unmatched value, accuracy and expert insights.
Ecuador ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market Analysis
This report presents a strategic analysis of the Ecuador ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Ecuador ADHD (Attention Deficit Hyperactivity Disorder) Drugs Market, offering unmatched value, accuracy and expert insights.
Canada Oncology Therapeutics Market Analysis
Canada's oncology therapeutics market is likely to grow at a CAGR of 8.4% from a market size of $14.53 Bn in 2022 to $27.7 Bn in 2030. The market is growing primarily due to the rise in cancer prevalence, population growth, and increased consumer knowledge of cancer therapies. Oncology drug market growth in Canada is anticipated to be constrained by the high development costs for new drugs, failure risk, and unfavourable side effects of anti-cancer drug therapy. This report is segmented by application, by drugs, by therapy, by route of administration, and by distribution channel. Some key players in this market include AstraZeneca, GlaxoSmithKline, Eli Lilly, Roche Diagnostics, Novartis, Pfizer, Merck, Gilead, Sanofi, Celgene Corporation, and others.
Brazil Pharmaceutical Market Analysis
This report presents a strategic analysis of the Brazil Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Brazil Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
Australia Anti Aging Therapeutics Market Analysis
Australia's anti-ageing therapeutics market is projected to grow from $7 Mn in 2022 to $27 Mn in 2030 with a CAGR of 18.03% for the year 2022-2030. The increasing elderly population and innovative technological advancements in Australia are responsible for the growth of the market. The Australian anti-ageing therapeutics market is segmented by product, treatment, target group, type of ageing, type of molecules, mechanism of action, ingredient, and by distribution channel. Clinuvel Pharmaceuticals, EZZ Life Science, and PharmatrophiX are the major competitors in the market.
Algeria Pharmaceutical Market Analysis
This report presents a strategic analysis of the Algeria Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Algeria Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
UK Dialysis Market Analysis
The UK dialysis market size was valued at $3.02 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.4% from 2022 to 2030 and will reach $4.5 Bn in 2030. Some of the major factors driving the market are increased funding for the research of novel medications, and an increase in patients with end-stage renal disease (ESRD). The market is segmented by Type, Product and Services, and End User. The major market players in the UK dialysis market are DaVita, Baxter, Medtronic, Fresenius Kabi, Physidia, and others.
UAE Alexipharmic Drugs Market Analysis
The UAE Alexipharmic drugs market size was valued at $xx Bn in 2022 and is estimated to expand at a CAGR of 5.70% from 2022-30 and will reach $xx Bn in 2030. The market is segmented by product type, indication, route of administration, end-user, and distribution channel. The UAE Alexipharmic Drugs market will grow because of growing awareness about the benefits of alexipharmic drugs among healthcare professionals and patients. The key market players are Julphar (UAE), Neopharma (UAE), Global Pharma (UAE), Pfizer Inc., and others.
Spain Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
Spain's Chronic Obstructive Pulmonary Disease (COPD) therapeutics market was valued at $352 Mn in 2022 and is estimated to expand at a CAGR of 6.1% from 2022 to 2030 and will reach $566 Mn in 2030. One of the main reasons propelling the growth of this market is the ageing population and government initiatives. The market is segmented by drug class and by distribution channel. Some key players in this market are Bioiberica, Ferrer, Laboratorios Esteve, Chiesi España, Almirall, Astellas Pharma, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, Teva Spain Limited and others.
Singapore Oncology Drugs Market Analysis
Singapore's oncology market size was valued at $xx Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of xx% from 2022 to 2030 and will reach $xx Bn in 2030. The market has been increasing over the past few decades, with the highest incidence rates. The market is segmented by drug class, therapy, indication, dosage form, and distribution channel. The key companies in the Singapore oncology drugs market are AstraZeneca, Raffles Medical Group, Wave Life Sciences, Sphaera Pharma, MSD Singapore, and others.
Saudi Arabia Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Saudi Arabia Oncology Therapeutics Market will reach a value of $6.6 Bn from $3.3 Bn in 2022, growing at a CAGR of 9.9% during 2022-2030. The Oncology Therapeutics Market in Saudi Arabia is dominated by a few domestic pharmaceutical companies such as Tabuk Pharmaceuticals, Jamjoom Pharma, and SPIMACO. The Oncology Therapeutics Market in Saudi Arabia is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Saudi Arabia Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
Portugal ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
This report presents a strategic analysis of the Portugal ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Portugal ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market, offering unmatched value, accuracy and expert insights.
Philippines Oncology Drugs Market Analysis
By 2030, it is anticipated that the Philippines oncology drugs market will reach a value of $xx Mn from $432.17 Mn in 2022, growing at a CAGR of xx% during 2022-30. The Oncology Drugs Market in the Philippines is dominated by a few domestic pharmaceutical companies such as United Laboratories, Pascual Laboratories, and Sannovex Pharmaceuticals. The oncology market in the Philippines is segmented into different therapeutic areas and different treatment types. The major factors affecting the Philippines oncology drugs market are the increasing disease burden of non-communicable diseases like cancer and the lack of healthcare facilities for cancer treatment in most areas of the Philippines.
Germany Women's Health Market Analysis
Germany's Women’s Health Market is projected to grow from $1.462 Bn in 2022 to $1.852 Bn by 2030, registering a CAGR of 3.0% during the forecast period of 2022-2030. Some key drivers of the Germany women's health market include an aging population, an increase in awareness and education about women's health issues, and an increase in government funding for research and development in the field. Some key players in the Germany women's health market include pharmaceutical companies such as Bayer AG, Merck KGaA, and Pfizer Inc.
Germany Lung Cancer Therapeutics Market Analysis
By 2030, it is anticipated that the Germany Lung Cancer Therapeutics Market will reach a value of $1.78 Bn from $1.09 Bn in 2022, growing at a CAGR of 6.3% during 2022-2030. The Lung Cancer Therapeutics Market in Germany is dominated by a few domestic pharmaceutical companies such as Boehringer Ingelheim, Merck KGaA, and Bayer. The Lung Cancer Therapeutics Market in Germany is segmented into different types of cancer and different therapy type. Some of the major factors affecting the German lung cancer therapeutics market are the prevalence of unhealthy lifestyles, demand for targeted therapies and the presence of highly efficient drugs.
China Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
China's Chronic Obstructive Pulmonary Disease (COPD) therapeutics market was valued at $1.46 Bn in 2022 and is estimated to expand at a CAGR of 8.6% from 2022 to 2030 and will reach $2.84 Bn in 2030. One of the main reasons propelling the growth of this market is the increased prevalence rate, air pollution, and smoking. The market is segmented by drug class and by distribution channel. Some key players in this market are Sinopharm Group, Hutchison China MediTech, Zhejiang Hisun Pharmaceutical, Haisco Pharmaceutical Group, Shanghai Sine Promod Pharmaceutical, Astellas Pharma, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, Teva China Limited and others.
Brazil Orphan Diseases Drugs Market Analysis
Brazil's Orphan Diseases Drugs Market is projected to grow from $3.870 Bn in 2022 to $9.114 Bn by 2030, registering a CAGR of 11.30% during the forecast period of 2022-2030. In Brazil, there is a significant population affected by rare diseases, with estimates suggesting that around 8 Mn Brazilians suffer from one of the more than 7,000 rare diseases currently known. The most common types of rare diseases in Brazil include genetic disorders, neurological conditions, and blood disorders. The key players in the Brazil orphan diseases drugs market include Pfizer, Roche Holding, Sanofi, Novartis International, Merck, and Amgen.
US Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
The US Chronic Obstructive Pulmonary Disease (COPD) therapeutics market was valued at $7.6 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.1% from 2022 to 2030 and will reach $11.4 Bn in 2030. One of the main reasons propelling the growth of this market is the introduction of new therapies, a government initiative. The market is segmented by drug class and distribution channel. Some key players in this market are GlaxoSmithKline, Astellas Pharma, AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, Teva US Limited, ResMed, Hill-Rom, and others.
Turkey Depression Therapeutics Market Analysis
Turkey's depression therapeutics market is expected to grow from $81 Mn in 2022 to $126 Mn in 2030 with a CAGR of 5.7% for the forecasted year 2022-2030. The rise in the depression prevalence in Turkey along with the new drug launches like N6A9 class of anti-depressants is responsible for the growth of the market. The Turkey depression therapeutics market is segmented by drug type, therapies, indication, and by end users. İLKO Pharmaceuticals, Afnan Teba, and Abbott are the major players in the Turkey depression therapeutics market.
Kuwait Pharmaceutical Market Analysis
This report presents a strategic analysis of the Kuwait Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Kuwait Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
Kuwait Insulin Market Analysis
This report presents a strategic analysis of the Kuwait Insulin Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Kuwait Insulin Market, offering unmatched value, accuracy and expert insights.
